Search

Search Constraints

You searched for: Author/Creator Buzzoni, Roberto

Search Results

1. A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors. Issue 6 (June 2018)

3. Diagnosis and management of typical and atypical lung carcinoids. (April 2016)

4. Diagnosis and management of typical and atypical lung carcinoids. (April 2016)

5. Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge. Issue 2 (April 2019)

6. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Issue 10022 (5th March 2016)

7. Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT‐4 lung subgroup analysis. Issue 1 (9th November 2017)

8. Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review. (July 2015)

9. Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10 (October 2017)

10. Markers of Systemic Inflammation in Neuroendocrine Tumors: A Pooled Analysis of the RADIANT-3 and RADIANT-4 Studies. Issue 2 (February 2021)